Immunome Stock Performance
as on October 12, 2026 at 2:16 pm IST
Day's Low
Day's High
$18.90$19.72
3.32%
Downside
0.87%
Upside
52 Week's Low
52 Week's High
$13.53$30.0630.77%
Downside
53.76%
Upside
Immunome share price movements today
- Previous Close
- $19.31
- Open
- $19.05
- Volume
- 896.4K
- Market Cap
- $2.3B
- Day's Low - High
- $18.90 - $19.72
- 52 Week Low - High
- $13.53 - $30.06
Immunome Historical Returns
- 1 Month Return
- -20.75 %
- 3 Month Return
- -16.27 %
- 1 Year Return
- + 40.45 %
- 3 Year Return
- + 133.29 %
- 5 Year Return
- + 12.23 %
Immunome Stock Fundamentals & Key Indicators
Check Immunome market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.3B
EPS (TTM)
-2.54
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-7.7
Industry PE ratio
-11.21
PEG Ratio
-0.46
EBITDA
-250.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-50.56%
Immunome vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Immunome with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $2.3B | 12.23% | -7.70 | 0.00% | 0.00% | |
| Neutral | $89.8B | -27.68% | -28.20 | -12.57% | 0.00% | |
| StrongBuy | $129.3B | 183.05% | 29.45 | 86.04% | 0.00% | |
| Buy | $76.9B | 37.12% | 17.83 | 84.86% | 0.50% |
Stock Returns calculator for Immunome Stock including INR - Dollar returns
The Immunome stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Immunome investment value today
Current value as on today
₹1,51,684
Returns
₹51,684
(+51.68%)
Returns from Immunome Stock
₹40,445 (+40.45%)
Dollar Impact
₹11,238 (+11.24%)
Analyst Recommendation on Immunome Stock
Based on 5 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Immunome. Average target price of $35.2
Immunome Share Price Target
Get share price movements and forecasts by analysts on Immunome.
What analysts predicted
44.46%UPSIDE
Target Price
$35.2
Current Price
$19.55
Analyzed by
5 Analysts
High
$40
Target
$35.20
Low
$35
Immunome target price $35.2, a slight upside of 44.46% compared to current price of $19.55. According to 5 analysts rating.
Indian Investors' Interest in Immunome Stock
Search interest for Immunome Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Immunome Quarterly Profit & Loss
All numbers in Millions USD
Immunome Annual Profit & Loss
All numbers in Millions USD
Immunome Quarterly Cash Flow
All numbers in Millions USD
Immunome Annual Cash Flow
All numbers in Millions USD
Immunome News & Key Events
Today's Timeline - 30 September
Wed, 05:20 PM
-Immunome receives FDA clearance for IM-1340, a potential first-in-class treatment for advanced solid tumors.
Thu, 01:40 AM
-Stifel initiates coverage of Immunome with a Hold rating and $24 price target, citing risks in the market.
Insights on Immunome
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, IMNM has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 698.2%
NEGATIVE IMPACTPrice Dip
In the last 7 days, IMNM stock has moved down by -7.7%
About Immunome
| Organisation | Immunome |
| Headquarters | 18702 North Creek Parkway, Bothell, WA, 98011, US |
| Industry | Biotechnology |
| CEO | Clay Siegall |
Key Management of Immunome
Name | Title |
|---|---|
Dr. Clay B. Siegall Ph.D. | Chairman, President & CEO |
Mr. Max Rosett | Chief Financial Officer |
Dr. Robert J. Lechleider M.D. | Chief Medical Officer |
Dr. Philip Tsai | Chief Technical Officer |
Dr. Jack Higgins Ph.D. | Chief Scientific Officer |
Ms. Sandra G. Stoneman Esq., J.D. | Chief Legal Officer, General Counsel & Corporate Secretary |
FAQs
What is Immunome share price today?
Immunome share price today is $19.55 as on at the close of the market. Immunome share today touched a day high of $19.72 and a low of $18.90.
What is the 52 week high and 52 week low for Immunome share?
Immunome share touched a 52 week high of $30.06 on and a 52 week low of $13.53 on . Immunome stock price today i.e. is closed at $19.55,which is 34.96% down from its 52 week high and 44.44% up from its 52 week low.
What is Immunome's market capitalisation today?
Immunome market capitalisation is $0.00T as on .
How to invest in Immunome Stock (IMNM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Immunome on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Immunome Stock (IMNM) from India?
Indian investors can start investing in Immunome (IMNM) shares with as little as ₹95.76000213623047 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in Immunome stock (as per the Rupee-Dollar exchange rate as on ).
Based on Immunome share’s latest price of $19.55 as on October 12, 2026 at 8:46 am IST, you will get 0.5115 shares of Immunome. Learn more about
fractional shares .
What are the returns that Immunome has given to Indian investors in the last 5 years?
Immunome stock has given 12.23% share price returns and 28.2% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?